Uniphage Inc.

Uniphage Inc. is a startup focused on developing next-gen safe and efficient microbe-based antimicrobials for agriculture and beyond. Their goal is to become a leader in curing fungal and bacterial diseases across agriculture, starting with reducing the use of dangerous fungicides, bactericides, and antibiotics in plant agriculture. The company's current R&D program is directed at addressing citrus greening disease, a bacterial disease affecting the US citrus industry, and creating novel microbe-based solutions for fungal diseases. They have garnered significant recognition and support, including NSF SBIR Phase I, Plug&Play Agritech Accelerator, MassChallenge US (Summer 2021), MassChallenge DoD-sponsored track, MassChallenge & IBM AI Program, Halcyon Fellow, Panacea Stars Develop SS2021 at Oxford University, Project Enginuity (SBIR Accelerator), Hangar Incubator by the National University of Singapore, and participation in the iGEM Venture Creation Lab. They have also achieved recognition as winners and finalists in various startup competitions and have received extensive non-dilutive funding. Notably, they have received a $256.00K grant investment on 11 April 2022 from the National Science Foundation. With their cutting-edge deep learning model to predict phages accurately and precisely, Uniphage Inc. is poised to make a significant impact on agriculture and biotechnology.